Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33


Stem cell therapy for amyotrophic lateral sclerosis.

Mao Z, Zhang S, Chen H.

Cell Regen (Lond). 2015 Nov 19;4:11. eCollection 2015.


Amyotrophic Lateral Sclerosis: New Perpectives and Update.

Orsini M, Oliveira AB, Nascimento OJ, Reis CH, Leite MA, de Souza JA, Pupe C, de Souza OG, Bastos VH, de Freitas MR, Teixeira S, Bruno C, Davidovich E, Smidt B.

Neurol Int. 2015 Sep 24;7(2):5885. doi: 10.4081/ni.2015.5885. eCollection 2015 Sep 24. Review.


Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiation.

Xu L, Ryu J, Hiel H, Menon A, Aggarwal A, Rha E, Mahairaki V, Cummings BJ, Koliatsos VE.

Stem Cell Res Ther. 2015 May 14;6:93. doi: 10.1186/s13287-015-0087-0.


Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis.

Goutman SA, Chen KS, Feldman EL.

Neurotherapeutics. 2015 Apr;12(2):428-48. doi: 10.1007/s13311-015-0339-9.


Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.

Itakura G, Kobayashi Y, Nishimura S, Iwai H, Takano M, Iwanami A, Toyama Y, Okano H, Nakamura M.

PLoS One. 2015 Feb 23;10(2):e0116413. doi: 10.1371/journal.pone.0116413. eCollection 2015.


Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review.

Vishwakarma SK, Bardia A, Tiwari SK, Paspala SA, Khan AA.

J Adv Res. 2014 May;5(3):277-94. doi: 10.1016/j.jare.2013.04.005. Epub 2013 May 7. Review.


Adult human neural stem cell therapeutics: Current developmental status and prospect.

Nam H, Lee KH, Nam DH, Joo KM.

World J Stem Cells. 2015 Jan 26;7(1):126-36. doi: 10.4252/wjsc.v7.i1.126. Review.


Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell lines.

Tajiri N, Quach DM, Kaneko Y, Wu S, Lee D, Lam T, Hayama KL, Hazel TG, Johe K, Wu MC, Borlongan CV.

PLoS One. 2014 Mar 10;9(3):e91408. doi: 10.1371/journal.pone.0091408. eCollection 2014.


Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury.

Sontag CJ, Nguyen HX, Kamei N, Uchida N, Anderson AJ, Cummings BJ.

Stem Cells Transl Med. 2013 Oct;2(10):731-44. doi: 10.5966/sctm.2012-0175. Epub 2013 Aug 27.


Transplantation of human fetal-derived neural stem cells improves cognitive function following cranial irradiation.

Acharya MM, Christie LA, Hazel TG, Johe KK, Limoli CL.

Cell Transplant. 2014;23(10):1255-66. doi: 10.3727/096368913X670200. Epub 2013 Jul 17.


Amelioration of motor/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation.

van Gorp S, Leerink M, Kakinohana O, Platoshyn O, Santucci C, Galik J, Joosten EA, Hruska-Plochan M, Goldberg D, Marsala S, Johe K, Ciacci JD, Marsala M.

Stem Cell Res Ther. 2013 May 28;4(3):57. doi: 10.1186/scrt209.


Neural stem cells as a therapeutic approach for amyotrophic lateral sclerosis.

Ferraiuolo L, Frakes A, Kaspar BK.

Mol Ther. 2013 Mar;21(3):503-5. doi: 10.1038/mt.2013.24. No abstract available.


Commentary on "the promise and the reality of stem-cell therapies for neurodegenerative diseases".

Koliatsos VE, Xu L.

Cerebrum. 2010 Nov;2010:25. Epub 2010 Dec 15. No abstract available.


Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis.

Popescu IR, Nicaise C, Liu S, Bisch G, Knippenberg S, Daubie V, Bohl D, Pochet R.

Stem Cells Transl Med. 2013 Mar;2(3):167-74. doi: 10.5966/sctm.2012-0042. Epub 2013 Feb 14.


Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research.

Teng YD, Yu D, Ropper AE, Li J, Kabatas S, Wakeman DR, Wang J, Sullivan MP, Redmond DE Jr, Langer R, Snyder EY, Sidman RL.

Curr Neuropharmacol. 2011 Dec;9(4):574-85. doi: 10.2174/157015911798376299.


Strategies for enrichment and selection of stem cell-derived tissue precursors.

Bernstein HS, Hyun WC.

Stem Cell Res Ther. 2012 May 10;3(3):17. doi: 10.1186/scrt108. Review.


Cell-Based Neurorestorotherapy in Amyotrophic Lateral Sclerosis - Scientific Truth should Rely on Facts, but Not Conjecture.

Chen L, Xi H, Huang H.

Front Integr Neurosci. 2011 Dec 20;5:83. doi: 10.3389/fnint.2011.00083. eCollection 2011. No abstract available.


Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS.

Lepore AC, O'Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ.

PLoS One. 2011;6(10):e25968. doi: 10.1371/journal.pone.0025968. Epub 2011 Oct 5.


Stem cell technology for neurodegenerative diseases.

Lunn JS, Sakowski SA, Hur J, Feldman EL.

Ann Neurol. 2011 Sep;70(3):353-61. doi: 10.1002/ana.22487. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk